United States · FDA National Drug Code directory
Tizanidine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-6756_4ccf302b-0c01-4e14-81a5-2904b7116e78
- Product NDC
- 50090-6756
- Form
- TABLET
- Composition / generic term
- Tizanidine
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210615
- Source listing expiry
- 20261231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 TABLET in 1 BOTTLE (50090-6756-0) · 50090-6756-0
- 60 TABLET in 1 BOTTLE (50090-6756-2) · 50090-6756-2
- 15 TABLET in 1 BOTTLE (50090-6756-3) · 50090-6756-3
- 30 TABLET in 1 BOTTLE (50090-6756-4) · 50090-6756-4
- 90 TABLET in 1 BOTTLE (50090-6756-6) · 50090-6756-6
- 14 TABLET in 1 BOTTLE (50090-6756-7) · 50090-6756-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →